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Dear Editor, 
  We read with interest the study by Chailurkit et al [1], published recently in your 
journal. The authors provide a global report regarding the percentage of C3 epimer of 
25(OH) D and its determinants in a representative sample of an Asian adult 
population. In concordance with previous observations, serum 3-epi-25(OH) D3 was 
detected in all samples, ranging from 1.8 to 24.8% of total 25(OH) D3, with the 
majority of distribution accounting for approximately 5-10%. Interesting correlations 
regarding age, male gender and rural residence were also evident, although they 
predicted only a small amount of variation of 3-epi-25(OH) D3 /total 25(OH) D3 
ratio.   
 Particular considerations might be of interest towards a more holistic interpretation of 
these findings. First of all, as the scientific community elapses the era of vitamin D 
supplementation for disease outcomes, we consider that until the potential biological 
actions of 3-epi-25(OH) D3, are elucidated from future studies, assaying the epimers 
separately could provide the most rational way of understanding, targeting and 
treating vitamin D deficiency and insufficiency. In clinical terms, if epimers represent 
a biologically inactive compound of vitamin homeodynamics, the rough estimates of 
25(OH)D reserve, although not altered in this study, are likely  to be affected, 
particularly in supplementation trials where vitamin D3 is used. The study by 
Chailurkit et al [1] provides data from samples with no previous vitamin D3 
supplementation. On the other hand, if future studies derive a biological role for 3-
epi-25(OH) D3, it could be hypothesized that it manifests a distinct role to that of 
25(OH) D3. 
 Secondly, previous data have reported that epimers might play a role in disease 
activity in several diseases, including Alzheimer’s disease, type 1 diabetes and 
rheumatoid arthritis [2].  Analysis of 10 forms of vitamin D revealed that the 3-epi-
25(OH)D3 form is present at significantly higher levels in those suffering from s 
Alzheimer disease, type 1 diabetes and rheumatoid arthritis [healthy controls (6.093 ± 
6.711 nmol/L; combined disease = 22.433 ± 13.535 nmol/L, t(52.5) = -6.411; P < 
.001].  Furthermore, both 3-epi-25(OH)D level and proportion, but not the epimer-
free 25OHD, showed good diagnostic power for the chronic disease status (AUC = 
0.880, P < .001).  These results warrant further investigation in large scale studies, 
along with an expansion to other chronic diseases that have been previously linked to 
vitamin D. 
 Finally, we would like to emphasize on the need for similar studies from a wide 
range of infant samples. While, previous data indicated that neonatal and infant 
vitamin D stores are reliant from maternal ones [3], routine accurate measurement of 
epimers, could overcome the technical flaws provoked by the presence of a significant 
percentage of epimers as a fraction of total vitamin D levels. 
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